National Health Security Amendment Commencement Proclamation 2013

Overview

The National Health Security Amendment Act 2012 was enacted to address concerns related to the regulation of Security Sensitive Biological Agents (SSBAs) that could potentially be used as bio-weapons. This legislation was introduced to enhance the existing regulatory framework established under the National Health Security Act 2007. The Act was passed by the Parliament of Australia and received Royal Assent on 10 December 2012. Its primary objective is to streamline the reporting regime for both registered and non-registered entities involved in handling SSBAs. This initiative was driven by feedback from the regulated community, Australian Intelligence Community, and SSBA Regulatory Scheme Inspectors. The streamlined reporting regime aims to improve the effectiveness of the regulatory scheme by addressing identified gaps and ensuring better oversight and compliance. The National Health Security Amendment Act 2012 includes consequential amendments to the National Health Security Regulations 2008, which were incorporated through Schedule 2. The commencement of the Act was proclaimed on 31 March 2013, ensuring that the legislative changes would be implemented in a timely manner. The development of the Act involved consultations with various government departments and agencies, including the Attorney-General’s Department, the Department of Prime Minister and Cabinet, and the Australian Government Solicitor, as well as broader consultations with states and territories, the Office of the Gene Technology Regulator, and other relevant stakeholders. The legislative instrument also aligns with a Statement of Compatibility with Human Rights, reinforcing its adherence to human rights standards.

Scope and Application

The National Health Security Amendment Act 2012 applies to entities involved with Security Sensitive Biological Agents (SSBAs), including both registered and non-registered entities, aiming to establish a streamlined reporting regime to enhance the regulatory controls established under the National Health Security Act 2007. This legislation pertains to individuals and entities that handle SSBAs that could potentially be used as bio-weapons. The Act operates nationally and is subject to the Commonwealth's jurisdiction, with its reach extending to all states and territories in Australia. The primary aim is to ensure that the SSBA regulatory scheme is effective in mitigating risks associated with the misuse of these agents. The commencement of the Act is fixed by Proclamation, with Schedules 1 and 2 set to begin on 31 March 2013, unless they are commenced within six months of receiving Royal Assent, which was granted on 10 December 2012. The Act also includes consequential amendments to the National Health Security Regulations 2008. Any exclusions, exemptions, or thresholds are detailed within the Act and the associated regulations, which may be further elaborated upon through subordinate instruments.

Key Provisions

The National Health Security Amendment Act 2012 primarily amends the National Health Security Act 2007 to introduce new provisions regarding the regulation of Security Sensitive Biological Agents (SSBAs). Key sections of this amendment include the streamlined reporting regime outlined in Schedule 1, which affects both registered and non-registered entities. These changes aim to enhance the effectiveness of the regulatory scheme in response to concerns raised by various stakeholders. Section 1 of the Act establishes the commencement date for these provisions, while sections 2 and 3 of the Act commenced immediately upon Royal Assent on 10 December 2012. The Act imposes specific obligations on entities handling or intending to handle SSBAs. Registered entities must now comply with a more streamlined reporting process, ensuring that any changes in the possession, use, or transfer of SSBAs are promptly reported to the relevant authorities. Non-registered entities, who were previously exempt from detailed reporting, are now also required to provide basic information about their handling of SSBAs. This change aims to improve oversight and security around the use of these potentially dangerous materials. The Act also mandates the amendment of the National Health Security Regulations 2008 to align with the new reporting requirements. Failure to comply with the new reporting requirements can lead to significant consequences. The Act does not explicitly outline specific offences or penalties in the provided text, but violations of regulatory controls under the National Health Security Act 2007 can typically result in substantial fines and potential imprisonment. For instance, unauthorised possession of SSBAs carries a maximum penalty of 10 years' imprisonment or a fine of up to $1.1 million. The precise penalties for breaches under the amended Act would be detailed in the National Health Security Regulations 2008, which have been updated to reflect the new requirements. Compliance with these regulations is crucial to avoid legal repercussions and ensure the security of SSBAs.